Quantcast

Posts related to ‘Drug companies’

biotech

Nymox Tries for Recovery on Safety Profile of NX-1207 for Prostate Cancer

Posted: March 5, 2013 at 11:40 am

Nymox Pharmaceutical Corp. (NASDAQ: NYMX) took a mystery beating last Friday, to the point that a single stock circuit breaker was triggered for a halt. The company said that it had no ...
Read Full Story »
Pills

J&J, Bayer Fail to Gain FDA Approval for Blood Thinner

Posted: March 5, 2013 at 7:55 am

The U.S. Food and Drug Administration (FDA) last night rejected an application from Johnson & Johnson (NYSE: JNJ) and Germany’s Bayer A.G. to extend the use of the two companies’ ...
Read Full Story »
Wall St Bull statue

Key Changes Made on the UBS Key Call List (UBS, WCRX, STZ, BUD)

Posted: February 15, 2013 at 10:00 am

We wrote at great length last month about the Key Call and Conviction Buy lists from the major Wall St. firms, bulge bracket and otherwise. The reason these lists are ...
Read Full Story »
biotech

JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)

Posted: February 8, 2013 at 10:10 am

Investing in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited pipelines or their very survival depends on a single binary ...
Read Full Story »
health care

Major Breakthrough in Lung Cancer Study — Treatment or Cure? (ONCY)

Posted: February 8, 2013 at 9:30 am

Oncolytics Biotech Inc. (NASDAQ: ONCY) just reasserted its position on the map again. The company has announced test results showing tumor shrinkage data from its U.S. Phase II clinical trial ...
Read Full Story »
biotech

Opexa Gets on the Map with Huge MS Pact

Posted: February 5, 2013 at 9:10 am

Opexa Therapeutics Inc. (NASDAQ: OPXA) is not just soaring this Tuesday. It is rising exponentially after securing an option and license agreement with Merck Serono on its multiple sclerosis treatment. ...
Read Full Story »
uncertainty market evolution

Largest Non-Founder CEO Retirement Packages of Modern Business History

Posted: February 4, 2013 at 5:47 am

Corporate governance issues are sometimes a blessing for shareholders, but they also can crush the rights of shareholders in many cases. Tracking CEO pay of large public companies is now considered ...
Read Full Story »
Cattle

Animal Health Firm IPO Soars (ZTS)

Posted: February 1, 2013 at 10:23 am

Zoetis Inc. (NYSE: ZTS), a spin-off of the animal health business of Pfizer Inc. (NYSE: PFE), held its initial public offering this morning. The company offered 86.1 million shares at ...
Read Full Story »
76764023

Positive Clinical Study Could Provide a Tailwind for Obesity Drugs (VVUS, ARNA, OREX)

Posted: February 1, 2013 at 9:04 am

According to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese or very overweight. Obesity-related medical conditions include heart attack, ...
Read Full Story »
biotech

The Death of Celsion?

Posted: January 31, 2013 at 2:35 pm

The biotech sector is full of companies which will have great wins and horrible flops. The latter is the case today for Celsion (NASDAQ: CLSN). In fact, if you just ...
Read Full Story »
health care

Keryx Gets Back on the Map

Posted: January 28, 2013 at 1:56 pm

Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) has not been a household name in biotech investing, but the move on news on Monday has put the company on the map. After shares ...
Read Full Story »
76764023

Arena Risk: Possible Drag on All Weight-Loss Drugs

Posted: January 22, 2013 at 1:21 pm

Arena Pharmaceuticals Inc. (NASDAQ: ARNA) is posing yet one more threat to ambitious biotechs and drug-makers who are targeting the obesity market. Its stock is getting slapped by almost 10% ...
Read Full Story »
health care

Analyst Calls Cancer Treatments Major Biotech Focus in 2013 (AMGN, GSK, ALXN, ARIA, CELG, INCY, ONXX)

Posted: January 18, 2013 at 9:50 am

The dread and fear that can come with a cancer diagnosis have their roots in its killer nature. It is the number two cause of death in Americans, second only ...
Read Full Story »
Pills

Jefferies Top Global Pharmaceutical Stock Picks for 2013 (JEF, ABBV, NVS, SNY, PFE)

Posted: January 17, 2013 at 8:29 am

After a strong year of relative performance for pharmaceutical stocks in 2012, the analysts at Jefferies Group Inc. (NYSE: JEF) predict that 2013 could show more of the same. However ...
Read Full Story »
76764023

The Obesity Drug Stock Rally Has Started (OREX, ARNA, VVUS, BAC)

Posted: January 16, 2013 at 8:16 am

Back in December, we took an in-depth look at what has become a crowded race in the obesity drug market. As we pointed out then, the race has become a ...
Read Full Story »